Last 12 months
Inside the activity.
0 purchase rows · 106 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 19 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 9 |
| Feb 2026 | 0 | 24 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 16 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 8 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 16, 2019 Filed Oct 18, 2019 20:44 UTC |
DUNN JEFFREY WDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,475 | $15.82 | $23,335.98 |
DisclosureSEC source: 0001562180-19-005189 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,522 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 20:44 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
SaleCommon Stock | 427 | $15.82 | $6,755.57 |
DisclosureSEC source: 0001562180-19-005190 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,918 F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 16,006 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. It also includes 491 shares purchased pursuant to the SI-BONE, Inc. 2018 Employee Stock Purchase Plan on May 15, 2019. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:26 UTC |
Yerby Scott AChief Technology Officer
|
SaleCommon Stock | 10,936 | $16.30 | $178,222.90 |
DisclosureSEC source: 0001562180-19-005181 · primarydocument.xml · nonDerivative · entry 1 Yerby Scott A · CIK 0001754756 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 90,779 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $16.1100 to $16.7031, inclusive. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 22:55 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-19-005115 · primarydocument.xml · derivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,590 Underlying: Common Stock · 1,000 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 22:55 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
SaleCommon Stock | 1,000 | $17.71 | $17,712.70 |
DisclosureSEC source: 0001562180-19-005115 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,854 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.56 to $17.88, inclusive. F3 · balance_after: Includes 17,237 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 22:55 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,000 | $4.32 | $4,320.00 |
DisclosureSEC source: 0001562180-19-005115 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 19:23 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-004931 · primarydocument.xml · derivative · entry 3 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,554 Underlying: Common Stock · 5,000 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 19:23 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001562180-19-004931 · primarydocument.xml · nonDerivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 19:23 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
Exercise / conversionCommon Stock | 5,000 | $3.96 | $19,800.00 |
DisclosureSEC source: 0001562180-19-004931 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 23:25 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-19-004932 · primarydocument.xml · derivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,590 Underlying: Common Stock · 300 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 23:25 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
SaleCommon Stock | 300 | $20.00 | $6,000.00 |
DisclosureSEC source: 0001562180-19-004932 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,854 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 17,237 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 23:25 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
Exercise / conversionCommon Stock | 300 | $4.32 | $1,296.00 |
DisclosureSEC source: 0001562180-19-004932 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 23:40 UTC |
DUNN JEFFREY WDirector · Chairman, President & CEO
|
SaleCommon Stock | 25,497 | $19.08 | $486,398.62 |
DisclosureSEC source: 0001562180-19-004873 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 467,540 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.2061, inclusive. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| September 13, 2019 Filed Sep 16, 2019 16:29 UTC |
DUNN JEFFREY WDirector · Chairman, President & CEO
|
SaleCommon Stock | 14,503 | $19.16 | $277,931.14 |
DisclosureSEC source: 0001562180-19-004811 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 493,037 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $19.49, inclusive. F3 · balance_after: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 19:17 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-19-004666 · primarydocument.xml · derivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,890 Underlying: Common Stock · 1,200 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 19:17 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
SaleCommon Stock | 1,200 | $18.98 | $22,771.32 |
DisclosureSEC source: 0001562180-19-004666 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,854 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.89 to $19.15, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 17,237 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 19:17 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,200 | $4.32 | $5,184.00 |
DisclosureSEC source: 0001562180-19-004666 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 19:13 UTC |
Freund John GordonDirector · 10% owner
|
SaleCommon Stock | 152,424 | $18.40 | $2,805,180.81 |
DisclosureSEC source: 0001562180-19-004500 · primarydocument.xml · nonDerivative · entry 1 Freund John Gordon · CIK 0001296771 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partner V, L.P. Disclosed balance after: 3,819,985 F1 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.40 to $19.21, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, together with Yasunori Kaneko, are the managing directors of LLC and each may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund and Mr. Kaneko disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 19:13 UTC |
Skyline Venture Partners V LP10% owner
Skyline Venture Management V, LLC10% owner
|
SaleCommon Stock | 152,424 | $18.40 | $2,805,180.81 |
DisclosureSEC source: 0001562180-19-004501 · primarydocument.xml · nonDerivative · entry 1 Skyline Venture Partners V LP · CIK 0001419187 · 10% owner Skyline Venture Management V, LLC · CIK 0001434887 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P Disclosed balance after: 3,819,985 F1 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.40 to $19.21, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, together with Yasunori Kaneko, are the managing directors of LLC and each may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund and Mr. Kaneko disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. Read SEC document |
| August 23, 2019 Filed Aug 23, 2019 22:34 UTC |
Skyline Venture Partners V LP10% owner
Skyline Venture Management V, LLC10% owner
|
SaleCommon Stock | 180 | $20.03 | $3,605.40 |
DisclosureSEC source: 0001562180-19-004461 · primarydocument.xml · nonDerivative · entry 4 Skyline Venture Partners V LP · CIK 0001419187 · 10% owner Skyline Venture Management V, LLC · CIK 0001434887 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P Disclosed balance after: 3,972,409 Read SEC document |
| August 23, 2019 Filed Aug 23, 2019 22:34 UTC |
Freund John GordonDirector · 10% owner
|
SaleCommon Stock | 180 | $20.03 | $3,605.40 |
DisclosureSEC source: 0001562180-19-004460 · primarydocument.xml · nonDerivative · entry 4 Freund John Gordon · CIK 0001296771 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P. Disclosed balance after: 3,972,409 Read SEC document |
| August 22, 2019 Filed Aug 23, 2019 22:34 UTC |
Skyline Venture Partners V LP10% owner
Skyline Venture Management V, LLC10% owner
|
SaleCommon Stock | 2,185 | $20.05 | $43,807.07 |
DisclosureSEC source: 0001562180-19-004461 · primarydocument.xml · nonDerivative · entry 3 Skyline Venture Partners V LP · CIK 0001419187 · 10% owner Skyline Venture Management V, LLC · CIK 0001434887 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P Disclosed balance after: 3,972,589 F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.02 to $20.18, inclusive. Read SEC document |
| August 22, 2019 Filed Aug 23, 2019 22:34 UTC |
Freund John GordonDirector · 10% owner
|
SaleCommon Stock | 2,185 | $20.05 | $43,807.07 |
DisclosureSEC source: 0001562180-19-004460 · primarydocument.xml · nonDerivative · entry 3 Freund John Gordon · CIK 0001296771 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P. Disclosed balance after: 3,972,589 F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.02 to $20.18, inclusive. Read SEC document |
| August 21, 2019 Filed Aug 22, 2019 16:40 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 770 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · derivative · entry 6 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,554 Underlying: Common Stock · 770 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 21, 2019 Filed Aug 22, 2019 16:40 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
SaleCommon Stock | 770 | $20.03 | $15,421.48 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · nonDerivative · entry 4 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.18, inclusive. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 21, 2019 Filed Aug 22, 2019 16:40 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
Exercise / conversionCommon Stock | 770 | $3.96 | $3,049.20 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · nonDerivative · entry 3 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 21, 2019 Filed Aug 22, 2019 20:41 UTC |
Yerby Scott AChief Technology Officer
|
SaleCommon Stock | 5,138 | $20.13 | $103,409.96 |
DisclosureSEC source: 0001562180-19-004441 · primarydocument.xml · nonDerivative · entry 2 Yerby Scott A · CIK 0001754756 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 101,715 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.24, inclusive. Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 22:34 UTC |
Skyline Venture Partners V LP10% owner
Skyline Venture Management V, LLC10% owner
|
SaleCommon Stock | 18,144 | $20.17 | $366,017.10 |
DisclosureSEC source: 0001562180-19-004461 · primarydocument.xml · nonDerivative · entry 2 Skyline Venture Partners V LP · CIK 0001419187 · 10% owner Skyline Venture Management V, LLC · CIK 0001434887 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P Disclosed balance after: 3,974,774 F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.02 to $20.26, inclusive. F2 · ownership.nature: Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, together with Yasunori Kaneko, are the managing directors of LLC and each may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund and Mr. Kaneko disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 22:34 UTC |
Skyline Venture Partners V LP10% owner
Skyline Venture Management V, LLC10% owner
|
SaleCommon Stock | 27,067 | $20.14 | $545,040.06 |
DisclosureSEC source: 0001562180-19-004461 · primarydocument.xml · nonDerivative · entry 1 Skyline Venture Partners V LP · CIK 0001419187 · 10% owner Skyline Venture Management V, LLC · CIK 0001434887 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P Disclosed balance after: 3,992,918 F1 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.05 to $20.21, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F2 · ownership.nature: Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, together with Yasunori Kaneko, are the managing directors of LLC and each may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund and Mr. Kaneko disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 22:34 UTC |
Freund John GordonDirector · 10% owner
|
SaleCommon Stock | 18,144 | $20.17 | $366,017.10 |
DisclosureSEC source: 0001562180-19-004460 · primarydocument.xml · nonDerivative · entry 2 Freund John Gordon · CIK 0001296771 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P. Disclosed balance after: 3,974,774 F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.02 to $20.26, inclusive. F2 · ownership.nature: Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, together with Yasunori Kaneko, are the managing directors of LLC and each may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund and Mr. Kaneko disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 22:34 UTC |
Freund John GordonDirector · 10% owner
|
SaleCommon Stock | 27,067 | $20.14 | $545,040.06 |
DisclosureSEC source: 0001562180-19-004460 · primarydocument.xml · nonDerivative · entry 1 Freund John Gordon · CIK 0001296771 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P Disclosed balance after: 3,992,918 F1 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.05 to $20.21, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. F2 · ownership.nature: Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, together with Yasunori Kaneko, are the managing directors of LLC and each may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund and Mr. Kaneko disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 16:40 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,930 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · derivative · entry 5 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,324 Underlying: Common Stock · 3,930 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 16:40 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
SaleCommon Stock | 3,930 | $20.01 | $78,628.69 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · nonDerivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896 F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.11, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 16:40 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
Exercise / conversionCommon Stock | 3,930 | $3.96 | $15,562.80 |
DisclosureSEC source: 0001562180-19-004440 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 20:41 UTC |
Yerby Scott AChief Technology Officer
|
SaleCommon Stock | 4,462 | $20.01 | $89,292.21 |
DisclosureSEC source: 0001562180-19-004441 · primarydocument.xml · nonDerivative · entry 1 Yerby Scott A · CIK 0001754756 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 106,853 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.07, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:10 UTC |
DUNN JEFFREY WDirector · Chairman, President & CEO
|
SaleCommon Stock | 40,000 | $19.64 | $785,740.00 |
DisclosureSEC source: 0001562180-19-004347 · primarydocument.xml · nonDerivative · entry 1 DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 507,540 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.00 to $20.00, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 16:12 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001562180-19-004349 · primarydocument.xml · derivative · entry 3 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,254 Underlying: Common Stock · 300 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 16:12 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
SaleCommon Stock | 300 | $20.00 | $6,000.00 |
DisclosureSEC source: 0001562180-19-004349 · primarydocument.xml · nonDerivative · entry 2 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 16:12 UTC |
Reckling W CarltonCMO and VP, Medical Affairs
|
Exercise / conversionCommon Stock | 300 | $3.96 | $1,188.00 |
DisclosureSEC source: 0001562180-19-004349 · primarydocument.xml · nonDerivative · entry 1 Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:11 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-19-004348 · primarydocument.xml · derivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,090 Underlying: Common Stock · 300 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:11 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
SaleCommon Stock | 300 | $20.00 | $6,000.00 |
DisclosureSEC source: 0001562180-19-004348 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,854 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 17,237 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:11 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
Exercise / conversionCommon Stock | 300 | $4.32 | $1,296.00 |
DisclosureSEC source: 0001562180-19-004348 · primarydocument.xml · nonDerivative · entry 1 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 20:09 UTC |
Yerby Scott AChief Technology Officer
|
SaleCommon Stock | 400 | $20.00 | $8,000.00 |
DisclosureSEC source: 0001562180-19-004346 · primarydocument.xml · nonDerivative · entry 2 Yerby Scott A · CIK 0001754756 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 111,315 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:09 UTC |
Yerby Scott AChief Technology Officer
|
SaleCommon Stock | 10,133 | $18.39 | $186,382.35 |
DisclosureSEC source: 0001562180-19-004346 · primarydocument.xml · nonDerivative · entry 1 Yerby Scott A · CIK 0001754756 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 111,715 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.11 to $18.67, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 12, 2019 Filed Aug 15, 2019 00:24 UTC |
Skyline Venture Partners V LP10% owner
Skyline Venture Management V, LLC10% owner
|
SaleCommon Stock | 400,000 | $18.25 | $7,300,000.00 |
DisclosureSEC source: 0001562180-19-004290 · primarydocument.xml · nonDerivative · entry 1 Skyline Venture Partners V LP · CIK 0001419187 · 10% owner Skyline Venture Management V, LLC · CIK 0001434887 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P Disclosed balance after: 4,019,985 F1 · ownership.nature: Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, together with Yasunori Kaneko, are the managing directors of LLC and each may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 23:41 UTC |
Freund John GordonDirector · 10% owner
|
SaleCommon Stock | 400,000 | $18.25 | $7,300,000.00 |
DisclosureSEC source: 0001562180-19-004288 · primarydocument.xml · nonDerivative · entry 1 Freund John Gordon · CIK 0001296771 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Skyline Venture Partners V, L.P Disclosed balance after: 4,019,985 F1 · ownership.nature: Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, together with Yasunori Kaneko, are the managing directors of LLC and each may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund and Mr. Kaneko disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 17:40 UTC |
Yerby Scott AChief Technology Officer
|
SaleCommon Stock | 649 | $17.07 | $11,078.43 |
DisclosureSEC source: 0001562180-19-004207 · primarydocument.xml · nonDerivative · entry 1 Yerby Scott A · CIK 0001754756 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 121,848 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. Read SEC document |
| August 02, 2019 Filed Aug 3, 2019 00:17 UTC |
Yerby Scott AChief Technology Officer
|
SaleCommon Stock | 376 | $17.81 | $6,696.56 |
DisclosureSEC source: 0001562180-19-004154 · primarydocument.xml · nonDerivative · entry 1 Yerby Scott A · CIK 0001754756 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,391 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| August 01, 2019 Filed Aug 3, 2019 00:17 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001562180-19-004153 · primarydocument.xml · derivative · entry 3 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,390 Underlying: Common Stock · 1,200 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date. Read SEC document |
| August 01, 2019 Filed Aug 3, 2019 00:17 UTC |
RECUPERO ANTHONY JChief Commercial Officer
|
SaleCommon Stock | 1,200 | $18.11 | $21,731.16 |
DisclosureSEC source: 0001562180-19-004153 · primarydocument.xml · nonDerivative · entry 2 RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,854 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.00 to $18.41, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 17,237 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.